Cheaper Breast Cancer Drug Does Well in Clinical Trial
FRIDAY, June 3, 2016 -- For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin (trastuzumab), a new study finds.
HER2-positive tumors contain certain...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | General Medicine | HER2 | Herceptin | Study | Women